YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Dietary Supplement: Lysine Chloride

First Posted Date: 2014-01-09

Last Posted Date: 2018-06-27

Lead Sponsor: Yale University

Target Recruit Count: 11

Registration Number: NCT02031354

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Evaluation of the Office on Violence Against Women's Domestic Violence Homicide Prevention Demonstrative Initiative

Completed

Conditions: Domestic Violence

Interventions: Other: Domestic Violence High Risk Team
Other: Lethality Assessment Program

First Posted Date: 2013-12-27

Last Posted Date: 2021-03-24

Lead Sponsor: Yale University

Target Recruit Count: 666

Registration Number: NCT02021838

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD)

Phase 1

Completed

Conditions: PTSD

Interventions: Drug: Riluzole

First Posted Date: 2013-12-24

Last Posted Date: 2020-04-01

Lead Sponsor: Yale University

Target Recruit Count: 18

Registration Number: NCT02019940

Locations: 🇺🇸
Clinical Neuroscience Division, National Center for PTSD, West Haven, Connecticut, United States

Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans

Phase 1

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Cocaine hydrochloride
Behavioral: Exercise
Drug: Nicotine

First Posted Date: 2013-12-23

Last Posted Date: 2023-02-16

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT02018263

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Drug: DEBIRI
Device: LC Bead M1
Procedure: TACE

First Posted Date: 2013-12-19

Last Posted Date: 2018-03-22

Lead Sponsor: Yale University

Target Recruit Count: 14

Registration Number: NCT02015754

Locations: 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States

Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors

Not Applicable

Completed

Conditions: Smoking
Schizophrenia

Interventions: Drug: Physostigmine

First Posted Date: 2013-12-11

Last Posted Date: 2023-10-25

Lead Sponsor: Yale University

Target Recruit Count: 80

Registration Number: NCT02008292

Locations: 🇺🇸
Yale Magnetic Resonance Research Center, New Haven, Connecticut, United States
🇺🇸
Yale PET Center, New Haven, Connecticut, United States
🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma

Phase 2

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Device: DEBDOX

First Posted Date: 2013-12-11

Last Posted Date: 2017-08-11

Lead Sponsor: Yale University

Target Recruit Count: 24

Registration Number: NCT02007954

Locations: 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States

Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, Gastric Bypass Surgeries

Active, not recruiting

Conditions: Obese Adolescents

First Posted Date: 2013-12-09

Last Posted Date: 2024-07-31

Lead Sponsor: Yale University

Target Recruit Count: 26

Registration Number: NCT02004561

Locations: 🇺🇸
Yale Pediatric Endocrinology Clinic, New Haven, Connecticut, United States

A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection

Not Applicable

Terminated

Conditions: Breast Cancer
Melanoma
Sarcoma
Colorectal Cancer
Brain Metastases
Renal Cell Carcinoma
Lung Cancer
Gastrointestinal Cancers

Interventions: Procedure: Gamma Knife Radiosurgery

First Posted Date: 2013-12-09

Last Posted Date: 2019-07-01

Lead Sponsor: Yale University

Target Recruit Count: 39

Registration Number: NCT02005614

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.

Not Applicable

Terminated

Conditions: Upper Gastrointestinal Bleeding

Interventions: Other: Outpatient Management of Low-risk Patients
Other: Inpatient Management of Low-risk Patients

First Posted Date: 2013-12-09

Last Posted Date: 2016-07-14

Lead Sponsor: Yale University

Target Recruit Count: 17

Registration Number: NCT02005705

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy